Manufacturing Address Mismatches on Medical Device Labeling May Become a Risk Indicator in Russia

A draft proposal from Russia's Ministry of Health would flag medical devices carrying a manufacturing site address on their labeling that cannot be verified against the official registration data — and for foreign manufacturers, this makes the accuracy of production site information in Russian registration documents a live compliance issue, not just a historical formality.

A manufacturing site change can create a regulatory mismatch in Russia if the new address appears on medical device labeling before it is reflected in the Russian registration data.

The Russian Ministry of Health is proposing a new risk indicator for medical devices aimed specifically at this type of mismatch. Roszdravnadzor (the Federal Service for Surveillance in Healthcare, Russia's federal healthcare regulator) would compare the manufacturing location or manufacturing site address shown on the labeling of a device already on the Russian market with the information in its registration certificate and State Register entry.

If the address shown on the labeling is not included in the Russian registration data, the discrepancy could trigger the proposed risk indicator and may lead to closer regulatory review.

For foreign manufacturers, the practical question is therefore not simply whether the manufacturing change was properly implemented at the corporate level. It is whether the Russian registration, local labeling and information provided to the authorized representative were updated in step with that change.

The proposal forms part of draft amendments to Ministry of Health Order No. 368n. As of September 8, 2026, the new indicator has not yet entered into force.

What Manufacturing Address Mismatches Could Trigger the New Risk Indicator in Russia?

The proposed risk indicator is narrowly defined. It would apply when the labeling of a medical device already on the Russian market shows a manufacturing location or manufacturing site address that is not included in the device's Russian registration certificate or State Register entry.

For a foreign manufacturer, this means that a manufacturing change can be valid and fully implemented at the global level but still create a Russian regulatory mismatch if the corresponding Russian registration has not been updated.

Manufacturers and authorized representatives should therefore compare the labeling actually being used with the current Russian registration data, paying particular attention to:

• the manufacturing location shown on the labeling;
• the address of each manufacturing site;
• manufacturer information where it is linked to a change in manufacturing location;
• the current registration certificate and State Register entry;
• manufacturing site information contained in the registration dossier;
• labeling revised after changes to manufacturing arrangements or registration documentation.

Products whose manufacturing setup has changed since the original Russian registration deserve particular attention.

Manufacturing Changes That Can Create Registration Mismatches in Russia

The presence of multiple manufacturing sites does not itself constitute the proposed risk indicator. The relevant issue is whether the manufacturing location or address shown on the labeling is included in the registered information for that specific medical device.

A risk indicator would also not automatically mean that a regulatory violation has occurred. It could prompt Roszdravnadzor to review the situation more closely and determine whether further supervisory action is needed.

Manufacturing address mismatches are one of the new risk indicators proposed for medical devices in Russia. We examined the broader expansion of the risk indicator framework and the other proposed indicators in our earlier article, “Russia Proposes New Medical Device Risk Indicators for 2026.”

Does a Manufacturing Site Change Require an Update to Russian Medical Device Registration Data?

Not always. A manufacturing site change requires a Russian regulatory assessment, but it does not necessarily require a new registration update. If the new manufacturing site or changed address is already included in the current registered information for the medical device, another registration update is not required solely because the manufacturing change took place. The manufacturer should instead confirm that the labeling used for the Russian market reflects the current registered information. If the actual manufacturing site or address has changed and the new information is not included in the Russian registration data, the Russian registration documentation needs to be brought into line with the current manufacturing setup. Depending on the change, this may require amendments to the registration dossier and related registration information.

This assessment is particularly important when:

• production has moved to another site;
• an additional manufacturing site has been added;
• the address of an existing site has changed;
• changes to the manufacturer affect the registered manufacturing information;
• medical device labeling has been revised to show the new manufacturing information.

The review should cover the manufacturing site actually used for the device, the registration certificate, the State Register entry, and the relevant sections of the registration dossier.

There is also an important reverse scenario. The Russian registration may already have been updated while products still carry an older version of the labeling. In that case, the registration data itself may be current, but the labeling used on the product no longer reflects it.

For a foreign manufacturer, this means that a manufacturing change should not be treated as complete for the Russian market simply because it has been approved internally. Its impact on the Russian registration and labeling also needs to be assessed.

Expert Tip from Unified Center of Expertise and Certification: separate from the proposed risk indicator, a change to the manufacturing address recorded in a Russian registration can also have consequences under Russia's existing manufacturing inspection rules. Roszdravnadzor lists a change to the manufacturing address stated in the registration certificate among the cases in which a manufacturing inspection is conducted.

Why Does Russia's Manufacturing Address Risk Indicator Matter to Foreign Medical Device Manufacturers?

Because global manufacturing changes and country-specific regulatory updates do not always happen at the same time. A foreign manufacturer may have legitimately moved production, added a site, or changed a manufacturing address while the Russian registration still contains the previous information.

This can create a Russia-specific regulatory gap: The manufacturing information may be correct in the manufacturer's current global records and labeling, but not yet reflected in the Russian registration data. Under the proposed risk indicator, that gap could become visible once a device carrying the new address is already on the Russian market.

The issue is particularly relevant for manufacturers that use several production sites, contract manufacturers, global labeling, or products that have been registered in Russia for many years. It also matters after corporate reorganizations, production transfers, acquisitions, or other changes that affect where a device is manufactured.

The Russian authorized representative should therefore be brought into the change-control process early enough to determine whether a manufacturing change affects the registration dossier, State Register entry, registration certificate, or labeling used for Russia.

For foreign manufacturers, the practical question is not simply: "Is our new manufacturing address correct?"

It is: "Has the Russian registration been updated before products carrying that address enter the Russian market?"

What Should Foreign Manufacturers Check Before Updated Medical Device Labeling Is Used in Russia?

Before a new manufacturing address is used on labeling for the Russian market, the manufacturer should compare the labeling for the specific device with its current Russian registration certificate, State Register entry, and registration dossier. The review should also confirm that the Russian authorized representative is working with the same current manufacturing information.

A Four-Step Check Before Updated Labeling Is Used in Russia

1. Identify the exact device and labeling version. Confirm the model or configuration concerned and establish which version of the labeling will actually be used for products supplied to Russia.
2. Verify the manufacturing site against the Russian registration data. Compare the manufacturing location and address shown on the labeling with the current registration certificate and State Register entry. The site or address used on the labeling should be present in the registered information for that device.
3. Review the registration dossier and amendment history. Check whether the manufacturing site has previously been added, moved, renamed, or given a new address and whether those changes were properly reflected in the Russian registration documentation.
4. Confirm that registration data and labeling are aligned before the updated information is used in Russia. If the new address appears on the labeling but not in the Russian registration data, determine what registration update is required. If the registration has already been updated but older labeling is still in use, the labeling process needs to be corrected instead.

The purpose of this review is to identify the source of any mismatch before products carrying the new manufacturing information reach the Russian market. The source may be an unrecorded manufacturing change, an incomplete Russian registration update, outdated labeling, or a breakdown in communication with the Russian authorized representative.

For foreign manufacturers, this review should also include the information provided to the Russian authorized representative, importer, and other supply-chain participants.

Manufacturing Site Changes and Russian Medical Device Registration

For foreign manufacturers, the main lesson is simple: a manufacturing change should not be treated as complete for Russia until the manufacturing site, Russian registration data and labeling all tell the same story.

Moving production, adding a site or changing an address may be a routine global change, but it can create a Russian regulatory gap if the local registration is not updated at the same pace. The proposed risk indicator would make that gap easier for Roszdravnadzor to identify once products carrying the new information are already on the market.

Unified Center of Expertise and Certification (UCEC Quality LLC) is one of the leading companies in medical device registration in Russia and the EAEU. Our specialists support manufacturers with medical device registration, amendments to registration documentation, and post-registration updates needed to keep regulatory information current.

We can assist with:

• reviewing manufacturing site information in Russian registration documentation;
• comparing medical device labeling with current registration data;
• assessing changes to manufacturing sites and addresses;
• determining whether registration amendments are required;
• preparing and supporting registration amendments;
• registering medical devices in Russia and the EAEU.

Changing a manufacturing site or address for a device registered in Russia? Unified Center of Expertise and Certification can assess the regulatory impact and help identify any registration or labeling updates required.